MedPage Today  Nov 18  Comment 
(MedPage Today) -- No quality of life benefit seen with extended dialysis in trial.
Benzinga  Nov 17  Comment 
Stifel initiated coverage on Proteon Therapeutics Inc (NASDAQ: PRTO) Monday with a Buy rating and $17 price target. Analysts led by Brian Klein commented that "Proteon is set to enter the growing ESRD market with lead Phase 3 product PRT-201,...
NPR  Nov 13  Comment 
A quarter of the dialysis patients who were in New York City when Hurricane Sandy hit missed at least one treatment due to power outages. Yet, not many are prepared for the next disaster.
NPR  Nov 10  Comment 
DaVita HealthCare partners, a provider of dialysis for kidney patients, says its expertise working with very sick patients can help hospitals expand into wellness and prevention.
MedPage Today  Nov 10  Comment 
(MedPage Today) -- Emory nephrologists will present case reports on the role of dialysis in Ebola.  Nov 7  Comment 
BOSTON ( TheStreet) -- An FDA advisory panel Thursday evening decided the benefits of Rockwell Medical's iron replacement therapy Triferic outweighed its risks for maintaining iron stores and hemoglobin in kidney dialysis patients. The panel...
FierceBiotech  Nov 4  Comment 
FDA reviewers have little doubt that Rockwell Medical's iron-replacement treatment for dialysis patients met its goals in late-stage trials, but the company, seeking agency approval, may have trouble convincing regulators that its Phase III...  Oct 24  Comment 
BOSTON (TheStreet) -- This week's Biotech Stock Mailbag opens with Rockwell Medical . Stuart A. writes:a"Adam, Rockwell Medical has an FDA advisory committee meeting coming up soon. Can you talk aboutathe issues that might be raisedathere?" ...
New York Times  Oct 23  Comment 
The dialysis chain had been accused of making illegal kickbacks to doctors for patient referrals.
MedPage Today  Oct 20  Comment 
(MedPage Today) -- Two nephrologists discuss the role of dialysis in Ebola treatment.


Companies in this industry provide dialysis services to patients with diabetes. These companies make a substantial portion of their revenue from prescribing diabetes drugs. They also heavily dependent on Medicare and Medicaid.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki